Warning: The NCBI web site requires JavaScript to function. more...
Alzheimer's disease: synaptic dysfunction and Abeta.
Shankar GM, Walsh DM.
Mol Neurodegener. 2009 Nov 23;4:48.
Related citations
Synaptic plasticity disruption by amyloid beta protein: modulation by potential Alzheimer's disease modifying therapies.
Rowan MJ, Klyubin I, Wang Q, Anwyl R.
Biochem Soc Trans. 2005 Aug;33(Pt 4):563-7. Review.
Synaptic memory mechanisms: Alzheimer's disease amyloid beta-peptide-induced dysfunction.
Rowan MJ, Klyubin I, Wang Q, Hu NW, Anwyl R.
Biochem Soc Trans. 2007 Nov;35(Pt 5):1219-23. Review.
Alzheimer's disease-associated neurotoxic mechanisms and neuroprotective strategies.
Pereira C, Agostinho P, Moreira PI, Cardoso SM, Oliveira CR.
Curr Drug Targets CNS Neurol Disord. 2005 Aug;4(4):383-403. Review.
Amyloid-β as a modulator of synaptic plasticity.
Parihar MS, Brewer GJ.
J Alzheimers Dis. 2010;22(3):741-63. Review.
Alzheimer's disease: synapses gone cold.
Koffie RM, Hyman BT, Spires-Jones TL.
Mol Neurodegener. 2011 Aug 26;6(1):63.
Spines, plasticity, and cognition in Alzheimer's model mice.
Spires-Jones T, Knafo S.
Neural Plast. 2012;2012:319836. Epub 2011 Nov 28.
Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway.
Canas PM, Porciúncula LO, Cunha GM, Silva CG, Machado NJ, Oliveira JM, Oliveira CR, Cunha RA.
J Neurosci. 2009 Nov 25;29(47):14741-51.
Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors.
Shemer I, Holmgren C, Min R, Fülöp L, Zilberter M, Sousa KM, Farkas T, Härtig W, Penke B, Burnashev N, Tanila H, Zilberter Y, Harkany T.
Eur J Neurosci. 2006 Apr;23(8):2035-47.
Beta-amyloid, neuronal death and Alzheimer's disease.
Carter J, Lippa CF.
Curr Mol Med. 2001 Dec;1(6):733-7. Review.
Soluble amyloid-beta peptides potently disrupt hippocampal synaptic plasticity in the absence of cerebrovascular dysfunction in vivo.
Hu NW, Smith IM, Walsh DM, Rowan MJ.
Brain. 2008 Sep;131(Pt 9):2414-24. Epub 2008 Aug 4.
[Alzheimer's disease, amyloid peptide and synaptic dysfunction].
Hémar A, Mulle C.
Med Sci (Paris). 2011 Aug-Sep;27(8-9):733-6. Epub 2011 Aug 31. Review. French.
Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory.
Turner PR, O'Connor K, Tate WP, Abraham WC.
Prog Neurobiol. 2003 May;70(1):1-32. Review.
Synaptic plasticity in animal models of early Alzheimer's disease.
Rowan MJ, Klyubin I, Cullen WK, Anwyl R.
Philos Trans R Soc Lond B Biol Sci. 2003 Apr 29;358(1432):821-8. Review.
Synaptic targeting by Alzheimer's-related amyloid beta oligomers.
Lacor PN, Buniel MC, Chang L, Fernandez SJ, Gong Y, Viola KL, Lambert MP, Velasco PT, Bigio EH, Finch CE, Krafft GA, Klein WL.
J Neurosci. 2004 Nov 10;24(45):10191-200.
Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.
Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L, Beach T, Kurth JH, Rydel RE, Rogers J.
Am J Pathol. 1999 Sep;155(3):853-62.
[Involvement of beta-amyloid in the etiology of Alzheimer's disease].
Tomiyama T.
Brain Nerve. 2010 Jul;62(7):691-9. Review. Japanese.
Mechanisms of synaptic homeostasis in Alzheimer's disease.
Small DH.
Curr Alzheimer Res. 2004 Feb;1(1):27-32. Review.
Is Alzheimer's disease a result of presynaptic failure? Synaptic dysfunctions induced by oligomeric beta-amyloid.
Nimmrich V, Ebert U.
Rev Neurosci. 2009;20(1):1-12. Review.
Cyclooxygenase-2 inhibition improves amyloid-beta-mediated suppression of memory and synaptic plasticity.
Kotilinek LA, Westerman MA, Wang Q, Panizzon K, Lim GP, Simonyi A, Lesne S, Falinska A, Younkin LH, Younkin SG, Rowan M, Cleary J, Wallis RA, Sun GY, Cole G, Frautschy S, Anwyl R, Ashe KH.
Brain. 2008 Mar;131(Pt 3):651-64.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on